Byooviz 10 mg/mL
ranibizumab-nuna · INJECTION, SOLUTION · Harrow Eye, LLC
No Recall History
Plain English
Byooviz is a injection, solution containing ranibizumab-nuna at 10 mg/mL, taken intravitreal. Manufactured by Harrow Eye, LLC.
Key Facts
- Brand Name
- Byooviz
- Generic Name
- ranibizumab-nuna
- NDC Code (Product)
82667-018- Manufacturer
- Harrow Eye, LLC
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- BLA761202
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 01/01/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Byooviz used for?
Byooviz contains ranibizumab-nuna. It is a injection, solution taken intravitreal. Consult your doctor for specific uses.
Is Byooviz a controlled substance?
Byooviz is not classified as a controlled substance by the DEA.
What is the generic name for Byooviz?
The generic name for Byooviz is ranibizumab-nuna. There are no other listed brand versions of ranibizumab-nuna.
What is the NDC code for Byooviz 10 mg/mL?
The NDC (National Drug Code) for Byooviz 10 mg/mL is 82667-018, listed by Harrow Eye, LLC.
Other Byooviz Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)